Robert Schulingkamp

Development of a Long-Acting Insulin Analog Using Albumin Fusion Technology

Alokesh Duttaroy, Palanisamy Kanakaraj, Blaire L. Osborn et al. · Diabetes · 2005 · 128 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint

Robert B. Raffa, Lauren J Holland, Robert Schulingkamp · Journal of Pharmacological and Toxicological Methods · 2001 · 99 citations

Life Sciences, Neuroscience, Pharmacology +16

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

Priyanka Nair-Gupta, Michael Diem, Dara Reeves et al. · Blood Advances · 2020 · 43 citations · Full text

Medicine, Immunology, Oncology +17

Energy-dependent UV light-induced disruption of (−)sulpiride antagonism of dopamine

Robert B. Raffa, Joseph M. Valdez, Lauren J Holland et al. · European Journal of Pharmacology · 2000 · 27 citations

Medicine, Neuroscience, Pharmacology +11

Regulatory Forum Opinion Piece ^* : Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry Survey

Sherry J. Morgan, Jessica A. Couch, Peggy Guzzie‐Peck et al. · Toxicologic Pathology · 2017 · 15 citations

Pharmacy, Pharmacology, Toxicology +16